Inhibitory effect of the sugarcane cystatin CaneCPI-4 on cathepsins B and L and human breast cancer cell invasion

Biological Chemistry

Volumn 389, Issue 4, 2008, Pages 447-453

  Gianotti, Andréia ^a   Sommer, César A ^a   Carmona, Adriana K ^b   Henrique Silva, Flávio ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cathepsin; Cysteine protease inhibitor; Matrigel; Phytocystatins; Saccharum officinarum; Tumor cell

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CYSTATIN; MATRIGEL; PROTEIN CANECPI 4; RECOMBINANT PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOCYTOSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERNALIZATION; METASTASIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUGARCANE;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CATHEPSIN B; CATHEPSINS; CELL LINE, TUMOR; CYSTATINS; HUMANS; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHARUM; SEQUENCE HOMOLOGY, AMINO ACID;

SACCHARUM OFFICINARUM;

EID: 44649198643     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.035     Document Type: Article

References (31)

1. Auerswald, E.A., Genenger, G., Assfalg-Machleidt, I., Machleidt, W., Engh, R.A., and Fritz, H. (1992). Recombinant chicken egg white cystatin variants of the QLVSG region. Eur. J. Biochem. 209, 837-845.
2. Barrett, A.J., Fritz, H., Grubb, A., Isemura, S., Järvinen, M., Katunuma, N., Machleidt, W., Müller-Esterl, W., Sasaki, M., and Turk, V. (1986). Nomenclature and classification of the proteins homologous with the cysteine proteinase inhibitor chicken cystatin. Biochem. J. 236, 312.
3. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., and Turk, V. (1988). The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7, 2593-2599.
4. Bradford, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Colella, R. and Casey, S.F. (2003). Decreased activity of cathepsins L q B and decreased invasive ability of PC3 prostate cancer cells. Biotech. Histochem. 78, 101-108.
6. Colella, R., Jackson, T., and Goodwyn, E. (2004). Matrigel® invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L + B activity. Biotech. Histochem. 79, 121-127.
7. Coopman, P.J., Do, M.T., Thompson, E.W., and Mueller, S.C. (1998). Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Cancer Res. 4, 507-515.
8. Gianotti, A., Rios, W.M., Soares-Costa, A., Nogaroto, V., Carmona, A.K., Oliva, M.L.V., Andrade, S.S., and Henrique-Silva, F. (2006). Recombinant expression, purification, and functional analysis of two novel cystatins from sugarcane (Saccharum officinarum). Protein Expr. Purif. 47, 483-489.
9. Gocheva, V. and Joyce, J.A. (2007). Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6, 60-64.
10. Gouet, P., Courcelle, E., Stuart, D.I., and Metoz, F. (1999). ESPript: analysis of multiple sequence alignments in Post-Script. Bioinformatics 15, 305-308.
11. Jedeszko, C. and Sloane, B.F. (2004). Cysteine cathepsins in human cancer. Biol. Chem. 385, 1017-1027.
12. Joyce, J.A. and Hanahan, D. (2004). Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3, 1516-1519.
13. Joyce, J.A., Baruch, A., Chehade, K., Meyer-Morse, N., Giraudo, E., Tsai, F.Y., Greenbaum, D.C., Hager, J.H., Bogyo, M., and Hanahan, D. (2004). Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443-453.
14. Keppler, D. (2006). Towards novel anti-cancer strategies based on cystatin function. Cancer Lett. 235, 159-176.
15. Knight, C.G. (1986). The characterization of enzyme inhibition. In: Proteinase Inhibitors, A.J. Barrett and G. Salvesen, eds. (Amsterdam, The Netherlands: Elsevier Science BV), pp. 23-51.
16. Kolkhorst, V., Stürzebecher, J., and Wiederanders, B. (1998). Inhibition of tumor cell invasion by protease inhibitors: correlation with the protease profile. J. Cancer Res. Clin. Oncol. 124, 598-606.
17. Krueger, S., Haeckel, C., Buehling, F., and Roessner, A. (1999). Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. 59, 6010-6014.
18. Krueger, S., Kellner, U., Buehling, F., and Roessner, A. (2001). Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Cancer Gene Ther. 8, 522-528.
19. Leatherbarrow, R.J. (1992). Grafit Version 3.0 (Staines, UK: Erithacus Software Ltd.).
20. Mohamed, M.M. and Sloane, B.F. (2006). Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775.
21. Nakai, K. and Horton, P. (1999). PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem. Sci. 24, 34-36.
22. Reis, E.M. and Margis, R. (2001). Sugarcane phytocystatins: identification, classification, and expression pattern analysis. Genet. Mol. Biol. 24, 291-296.
23. Roshy, S., Sloane, B.F., and Moin, K. (2003). Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22, 271-286.
24. Sameni, M., Moin, K., and Sloane, B.F. (2000). Imaging proteolysis by living human breast cancer cells. Neoplasia 2, 496-504.
25. Skrzydlewska, E., Sulkowska, M., Koda, M., and Sulkowski, S. (2005). Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 11, 1251-1266.
26. Sloane, B.F., Moin, K., Sameni, M., Tait, L.R., Rozhin, J., and Ziegler, G. (1994). Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J. Cell Sci. 107, 373-384.
27. Turk, V. and Bode, W. (1991). The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219.
28. Turk, B., Turk, D., and Turk, V. (2000). Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 1477, 98-111.
29. Vasiljeva, O., Reinheckel, T., Peters, C., Turk, D., Turk, V., and Turk, B. (2007). Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 13, 387-403.
30. Zajc, I., Sever, N., Bervar, A., and Lah, T.T. (2002). Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines. Cancer Lett. 187, 185-190.
31. Zajc, I., Frangež, L., and Lah, T.T. (2003). Expression of cathepsin B is related to tumorigenicity of breast cancer cell lines. Radiol. Oncol. 37, 233-240.